|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 471/08 | (2006.01) |
| A61K 45/06 | (2013.01) | ||
| C07D 471/18 | (2006.01) | ||
| C07D 498/18 | (2013.01) | ||
| C07D 498/18 | (2006.01) | ||
| C07D 471/18 | (2013.01) | ||
| A61K 31/395 | (2006.01) | ||
| C07D 471/08 | (2013.01) | ||
| A61K 31/53 | (2006.01) | ||
| A61P 31/18 | (2018.01) | ||
| A61K 31/5365 | (2006.01) | ||
| C07D 471/02 | (2006.01) | ||
| C07D 471/12 | (2006.01) | ||
| C07D 471/16 | (2006.01) | ||
| A61P 31/18 | (2006.01) |
| (11) | Number of the document | 3752144 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19754182.4 |
| Date of filing the European patent application | 2019-02-11 | |
| (97) | Date of publication of the European application | 2020-12-23 |
| (45) | Date of publication and mention of the grant of the patent | 2022-12-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2019/017409 |
| Date | 2019-02-11 |
| (87) | Number | WO 2019/160783 |
| Date | 2019-08-22 |
| (30) | Number | Date | Country code |
| 201862630974 P | 2018-02-15 | US |
| (72) |
EMBREY, Mark, W. , US
HARTINGH, Timothy John , US
LABROLI, Marc , US
RAHEEM, Izzat, T. , US
|
| (73) |
Merck Sharp & Dohme LLC ,
126 East Lincoln Avenue, Rahway, New Jersey 07065,
US
|
| (54) | TRICYCLIC HETEROCYCLE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS |
| TRICYCLIC HETEROCYCLE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS |